Exploring Serum Metabolic Markers for the Discrimination of Ccrcc From Renal Angiomyolipoma By Metabolomics

References

• Ghatalia P , RathmellWK. Systematic review: ClearCode 34 – a validated prognostic signature in clear cell renal cell carcinoma (ccRCC). Kidney Cancer2(1), 23–29 (2018).
   PubMedGoogle Scholar
• Nabi S , KesslerER, BernardB, FlaigTW, LamET. Renal cell carcinoma: a review of biology and pathophysiology. F1000Res.7(730), 1–10 (2018).
   Google Scholar
• Alhusban M , AlhamssS, AlzumailiB, Al-DaghminA. Ipsilateral synchronous clear and papillary renal cell carcinoma: a case report and review of the literature. Urol. Case Rep.16, 110–113 (2018).
   PubMedGoogle Scholar
• Clyne M . Kidney cancer: metabolomics for targeted therapy. Nat. Rev. Urol.9(7), 355 (2012).
   PubMedGoogle Scholar
• Rampersaud EN , KlatteT, BassGet al. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol. Oncol.32(1), 30, e39–13 (2014).
   Web of Science ®Google Scholar
• Battisti S , BraudG, RigaudJ, BouchotO. [Sporadic kidney cancer in patients younger than 45]. Prog. Urol.17(5), 934–938 (2007).
   PubMed Web of Science ®Google Scholar
• Pal SK , FiglinRA. Targeted therapies for renal cell carcinoma: understanding their impact on survival. Target. Oncol.5(2), 131–138 (2010).
   PubMed Web of Science ®Google Scholar
• Flum AS , HamouiN, SaidMAet al. Update on the diagnosis and management of renal angiomyolipoma. J. Urol.195(4 Pt 1), 834–846 (2016).
   PubMed Web of Science ®Google Scholar
• Lim RS , FloodTA, McinnesMDF, LavalleeLT, SchiedaN. Renal angiomyolipoma without visible fat: can we make the diagnosis using CT and MRI?Eur. Radiol.28(2), 542–553 (2018).
   PubMed Web of Science ®Google Scholar
• Hakim SW , SchiedaN, HodgdonT, McinnesMDF, DilauroM, FloodTA. Angiomyolipoma (AML) without visible fat: ultrasound, CT and MR imaging features with pathological correlation. Eur. Radiol.26(2), 592–600 (2016).
   PubMed Web of Science ®Google Scholar
• Catalano OA , SamirAE, SahaniDV, HahnPF. Pixel distribution analysis: can it be used to distinguish clear cell carcinomas from angiomyolipomas with minimal fat?Radiology247(3), 738–746 (2008).
   PubMed Web of Science ®Google Scholar
• Li Y , ZhaoJX, YangGJ, ZhangW, LouZY. Analysis of serum metabolite composition in patients with early stage clear cell renal cell carcinoma by 1HNMR spectroscopy metabonomic study. Acad. J. Second Mil. Med. Univ.33(1), 67–70 (2012).
   Google Scholar
• Lin L , HuangZZ, GaoYet al. LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery. Proteomics12(14), 2238–2246 (2012).
   PubMed Web of Science ®Google Scholar
• Yu M , XiangT, WuXet al. Diagnosis of acute pediatric appendicitis from children with inflammatory diseases by combination of metabolic markers and inflammatory response variables. Clin. Chem. Lab. Med.56(6), 1001–1010 (2018).
   PubMed Web of Science ®Google Scholar
• Zou H , XiangM, YeX, XiongY, XieB, ShaoJ. Reduction of urinary uric acid excretion in patients with proteinuria. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.1006, 59–64 (2015).
   PubMed Web of Science ®Google Scholar
• Zheng P , GaoHC, LiQet al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J. Proteome Res.11(3), 1741–1748 (2012).
   PubMed Web of Science ®Google Scholar
• Xie B , LiuA, ZhanX, YeX, WeiJ. Alteration of gut bacteria and metabolomes after glucaro-1,4-lactone treatment contributes to the prevention of hypercholesterolemia. J. Agric. Food Chem.62(30), 7444–7451 (2014).
   PubMed Web of Science ®Google Scholar
• Mamtimin B , XiaG, MijitMet al. Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics. Pharmacogn. Res.11(44), 698–706 (2015).
   Google Scholar
• Tong J , ZouY, JiangJet al. Cancer screening of asymptomatic individuals using 18F-FDG PET/CT in China: a retrospective study. Discov. Med.22(121), 181–188 (2016).
   PubMed Web of Science ®Google Scholar
• Lin CY , ChenHY, DingHJ, YenKY, KaoCH. FDG PET or PET/CT in evaluation of renal angiomyolipoma. Korean J. Radiol.14(2), 337–342 (2013).
   PubMed Web of Science ®Google Scholar
• Catchpole G , PlatzerA, WeikertCet al. Metabolic profiling reveals key metabolic features of renal cell carcinoma. J. Cell. Mol. Med.15(1), 109–118 (2011).
   PubMed Web of Science ®Google Scholar
• Falegan OS , BallMW, ShaykhutdinovRAet al. Urine and serum metabolomics analyses may distinguish between stages of renal cell carcinoma. Metabolites7(6), 1–17 (2017).
   Google Scholar
• Ganti S , WeissRH. Urine metabolomics for kidney cancer detection and biomarker discovery. Urol. Oncol.29(5), 551–557 (2011).
   PubMed Web of Science ®Google Scholar
• Kim K , AronovP, ZakharkinSOet al. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol. Cell Proteomics8(3), 558–570 (2009).
   PubMed Web of Science ®Google Scholar
• Lin L , HuangZ, GaoY, YanX, XingJ, HangW. LC-MS-based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. J. Proteome Res.10(3), 1396–1405 (2011).
   PubMed Web of Science ®Google Scholar
• Monteiro M , MoreiraN, PintoJet al. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients. J. Cell. Mol. Med.21(9), 2092–2105 (2017).
   PubMed Web of Science ®Google Scholar
• Monteiro MS , BarrosAS, PintoJet al. Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Sci. Rep.6, 37275 (2016).
   PubMed Web of Science ®Google Scholar
• Niziol J , BonifayV, OssolinskiKet al. Metabolomic study of human tissue and urine in clear-cell renal carcinoma by LC-HRMS and PLS-DA. Anal. Bioanal. Chem.410(16), 3859–3869 (2018).
   PubMed Web of Science ®Google Scholar
• Weiss RH . Metabolomics and metabolic reprogramming in kidney cancer. Semin. Nephrol.38(2), 175–182 (2018).
   PubMed Web of Science ®Google Scholar
• Zira AN , TheocharisSE, MitropoulosD, MigdalisV, MikrosE. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. J. Proteome Res.9(8), 4038–4044 (2010).
   PubMed Web of Science ®Google Scholar
• Lee JH , KimYH, KimK-Het al. Profiling of serum metabolites using MALDI-TOF and Triple-TOF mass spectrometry to develop a screen for ovarian cancer. Cancer Res. Treat.50(3), 883–893 (2018).
   PubMed Web of Science ®Google Scholar
• Jung J , JungY, BangEJet al. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling. Ann. Surg. Oncol.21(Suppl. 4), S736–S742 (2014).
   PubMedGoogle Scholar
• Lorenzi M , VannoniD, LeonciniR, CaldaroneR, MarinelloE. The determination of urinary oxypurines as markers of gastrointestinal tumors. Tumori.73(3), 289–294 (1987).
   PubMed Web of Science ®Google Scholar
• Kim K , YeoSG, YooBC. Identification of hypoxanthine and phosphoenolpyruvic acid as serum markers of chemoradiotherapy response in locally advanced rectal cancer. Cancer Res. Treat.47(1), 78–89 (2015).
   PubMed Web of Science ®Google Scholar
• Zheng H , JiJ, ZhaoLet al. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps. Oncotarget7(37), 59189–59198 (2016).
   PubMedGoogle Scholar
• Gao H , DongB, JiaJet al. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases. J. Cancer Res. Clin. Oncol.138(5), 753–761 (2012).
   PubMed Web of Science ®Google Scholar
• Hanzu FA , VinaixaM, PapageorgiouAet al. Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: an untargeted metabolomic approach. Obesity22(3), 698–704 (2014).
   PubMed Web of Science ®Google Scholar
• Liesenfeld DB , GrapovD, FahrmannJFet al. Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. Am. J. Clin. Nutr.102(2), 433–443 (2015).
   PubMed Web of Science ®Google Scholar
• Martin HM , HancockJT, SalisburyV, HarrisonR. Role of xanthine oxidoreductase as an antimicrobial agent. Infect. Immun.72(9), 4933–4939 (2004).
   PubMed Web of Science ®Google Scholar
• Itahana Y , HanR, BarbierS, LeiZ, RozenS, ItahanaK. The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene34(14), 1799–1810 (2015).
   PubMed Web of Science ®Google Scholar
• Ruggiero C , CherubiniA, BleAet al. Uric acid and inflammatory markers. Eur. Heart J.27(10), 1174–1181 (2006).
   PubMed Web of Science ®Google Scholar
• Walker JB . Metabolic control of creatine biosynthesis. II. Restoration of transamidinase activity following creatine repression. J. Biol. Chem.236, 493–498 (1961).
   PubMed Web of Science ®Google Scholar
• Xie B , WatersMJ, SchirraHJ. Investigating potential mechanisms of obesity by metabolomics. J. Biomed. Biotechnol.2012, 805683 (2012).
   PubMedGoogle Scholar
• Lew SW , BoschJP. Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. J. Am. Soc. Nephrol.2(4), 856–865 (1991).
   PubMed Web of Science ®Google Scholar